2C-B (Nexus): Therapeutic use

Last modified: Saturday, 20. June 2009 - 3:55 pm

In the 1970s, 2C-B was used in patients by a small number of psychotherapists in the United States. These therapists reported the drug created a warm, empathetic bond between them and their patients. The therapists also said the drug helped break down a patient’s ego defenses and inner resistances, allowing the patient to get in touch with suppressed emotions and repressed memories. However, medical usage was limited and had all but disappeared by the time 2C-B was made a Schedule I substance in 1995. Today, 2C-B is not recognized by most in the medical community as having any Therapeutic usefulness.
In the past several years, a few medical researchers have stated they believe some hallucinogens may have valid medical uses, particularly in psychiatry. Also, studies are underway in Baltimore and New Mexico on the possible uses of hallucinogens to treat drug and alcohol addictions. The U.S. Food and Drug Administration (FDA) has approved the studies. Recent advances in science have created opportunities for using hallucinogens as tools in learning how the brain functions.

Leave a comment

You have to be logged in, to leave a comment.